MaxLife Review: Starter Prices and the Thirty-Day Exit

MaxLife is worth comparing if you are comfortable paying for a three-month introduction and know how you would end it. The semaglutide headline is $89 a month for three months, billed as $267 now; tirzepatide is $120 a month for three months, billed as $360 now. Those offers then move to advertised monthly rates of $155 and $195. We would settle the cancellation date and refund terms before choosing the cheaper-looking introduction.

A February 2026 FDA warning letter about MaxLife's compounded-drug promotion also belongs in this decision.

Our recommendation is conditional: the posted introductory debit is useful information, but it does not settle the dose, dispensing pharmacy or terms of an individual order. Someone needing an immediate exit or an assured refund for an unused balance should resolve those points first.

The starter price lasts three months

The two product pages distinguish a Starter Kit from a regular monthly plan. They explicitly show the introductory total rather than just an annualized or monthly-looking minimum:

The separate monthly options are listed at $155 for semaglutide and $195 for tirzepatide. Before authorizing either route, confirm the total first charge, prescribed quantity, applicable taxes and date of the next payment. The offer shown on a product page is not an invoice for your chosen treatment.

The pages say medication and supplies are included in the membership; the tirzepatide page also lists provider review, ongoing messaging and overnight shipping. That is more useful than a bare medicine price, but it does not establish that every test or additional service is included. Our six-month cost guide explains how to keep care fees and pharmacy charges attached to the comparison.

“Cancel anytime” still requires thirty days' notice

The product FAQ says there is no long-term contract, but asks for cancellation notice at least thirty days before the next billing period. The terms say to email a cancellation request thirty days before the intended cancellation date. Those formulations need an actual date, particularly when a three-month introduction is ending.

The terms provide automatic renewal at the selected subscription frequency, or monthly if none is specified, at then-current rates. The advertised $155 and $195 continuing monthly amounts are not a promise that every future renewal will keep that price. Confirm the actual renewal amount and interval for the selected plan.

Ask when the next charge processes, when notice must be received and when cancellation takes effect. Get confirmation that the intended next renewal will stop. A monthly plan is not necessarily a plan that can end the day before another charge.

The terms also describe early-termination fees if a selected plan has a preset commitment, without establishing the amount for these Starter Kits. They say provider and medication access may be suspended at cancellation, while another clause describes paid-service access through the paid period. Confirm the financial and care end dates together rather than assuming the marketing phrase overrides those provisions. The subscription cancellation guide covers the records worth keeping.

A denial refund is different from a results guarantee

The terms promise to refund amounts paid for services if you are found ineligible. Separately, subscription payments are generally nonrefundable and partially used periods receive no credit. Physical offerings cannot be returned, refunded or exchanged, and shipped orders cannot be canceled. These distinctions do not establish an assured prorated return of an unused prepaid balance.

MaxLife also advertises a “6-Month Results Guarantee” and price-match language. The reviewed public product and policy pages do not establish the guarantee's full eligibility conditions, refund formula or claims deadline. We would not use that badge as a reason to disregard the written nonrefundable-payment provisions. Ask for the selected guarantee terms before relying on it.

The terms display “Last Updated on 09/11/2024.” We checked the accessible offer and policy in October 2026; that retrieval does not mean the company revised the contract this month.

Identify the treating practice as well as the platform

MaxLife's terms identify MaxLife Technologies Inc. and expressly say the company is not a healthcare provider. They refer to affiliated medical groups and third-party providers but do not establish the medical practice or individual who would treat you. The privacy notice uses the same platform name.

The program describes licensed-provider review, ongoing messaging and a video appointment when required for the patient's state. These are advertised care arrangements, not an independently verified clinician license or a guaranteed response time. Ask who is prescribing, how follow-up works and whom to contact about tolerability or a prescription question.

Dose increases need their own price question. The FAQ says a clinician reviews the request and that the prescription and membership will be adjusted accordingly. It does not establish an unchanged price for every possible dose. Confirm the selected dose, quantity and any resulting fee before treating the introductory figure as a complete continuing quote.

The pharmacy list does not identify your dispenser

One product answer names Hallandale Pharmacy, Red Rock Pharmacy and Strive Pharmacy as partners. Another answer on the tirzepatide page supplies a longer list, including Dirx and Southend, and says the dispenser varies by location, prescription and availability. A list gives leads to verify; it does not tell you which facility will fill your order.

Request the actual compounding and dispensing facility before relying on a general pharmacy claim. Check that facility's current relevant board record using our pharmacy verification checklist. We have not independently verified a license or a patient-specific pharmacy assignment.

The site markets compounded preparations, which it acknowledges are not FDA-approved. Its patient testimonials, weight-loss figures and claims that added B vitamins reduce side effects are not independent evidence about the preparation you would receive. We did not test those claims, receive medication or experience the service.

Read the dated FDA warning before choosing

FDA issued warning letter 721453 to MaxLife Technologies Inc. dba Maxlife on February 20, 2026, after reviewing maxlife.com in December 2025. FDA said pictured labels misleadingly suggested Maxlife compounded the drugs when it did not. The letter also addressed marketing that implied the compounded semaglutide and tirzepatide were FDA-approved or evaluated for safety and effectiveness.

We have not verified a response or closeout outcome. The dated letter should not be presented as a current recall or proof that a particular patient's preparation is defective. It reinforces the need to identify the actual pharmacy and discuss the proposed product with the treating clinician.

Confirm state eligibility and what follow-up includes

The product FAQ advertises service in all fifty states; the terms say some services are unavailable in certain states. Confirm the particular treatment and treating clinician for where you will be located. Neither a nationwide statement nor a named pharmacy proves that every preparation is available to you.

The pages describe monthly or quarterly shipping depending on the billing period and prescribed dose. Advertised overnight transport follows clinical and pharmacy processing; it is not a guaranteed next-day arrival after clicking a button. A fixed included lab allowance, repeat-testing schedule and individual appointment arrangement were not established.

For a shopper who has the upfront budget, MaxLife's stated three-month introduction may deserve a closer look. We would choose it only after obtaining the full order, actual care/pharmacy identities and a written renewal/cancellation answer. If the thirty-day notice or unused-balance risk does not fit, compare other provider reviews before committing.